Compounds > lysine
Page last updated: 2024-08-17

lysine and Hematologic Diseases

lysine has been researched along with Hematologic Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Azagra, A; Cobaleda, C1
Bodamer, O; Choi, J; Hung, C; Jung, YL; Lee, EA1
Hata, K; Iwasaki, Y; Kamura, H; Kawai, T; Nakabayashi, K; Nakamura, K; Ogata-Kawata, H; Takano, T1
Ge, K; Magnuson, T; Shpargel, KB; Starmer, J; Wang, C1
Brunskill, SJ; Doree, C; Estcourt, LJ; Murphy, MF; Stanworth, S; Trivella, M; Wardrop, D1
Brunskill, SJ; Desborough, M; Doree, C; Estcourt, LJ; Hopewell, S; Murphy, MF; Stanworth, SJ1

Reviews

3 review(s) available for lysine and Hematologic Diseases

ArticleYear
NSD2 as a Promising Target in Hematological Disorders.
    International journal of molecular sciences, 2022, Sep-21, Volume: 23, Issue:19

    Topics: Epigenesis, Genetic; Hematologic Diseases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Neoplasms; Repressor Proteins

2022
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    The Cochrane database of systematic reviews, 2013, Jul-29, Issue:7

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Erythrocyte Transfusion; Hematologic Diseases; Hemorrhage; Humans; Lysine; Platelet Transfusion; Thrombocytopenia; Tranexamic Acid

2013
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
    The Cochrane database of systematic reviews, 2016, Mar-15, Volume: 3

    Topics: Aminocaproic Acid; Antifibrinolytic Agents; Erythrocyte Transfusion; Hematologic Diseases; Hemorrhage; Humans; Lysine; Platelet Transfusion; Thrombocytopenia; Thromboembolism; Tranexamic Acid

2016

Other Studies

3 other study(ies) available for lysine and Hematologic Diseases

ArticleYear
Characterizing the molecular impact of KMT2D variants on the epigenetic and transcriptional landscapes in Kabuki syndrome.
    Human molecular genetics, 2023, 06-19, Volume: 32, Issue:13

    Topics: Abnormalities, Multiple; Epigenesis, Genetic; Hematologic Diseases; Humans; Leukocytes, Mononuclear; Lysine; Mutation; Myosin Type I; Vestibular Diseases

2023
Identification of a KDM6A somatic mutation responsible for Kabuki syndrome by excluding a conflicting KMT2D germline variant through episignature analysis.
    European journal of medical genetics, 2023, Volume: 66, Issue:8

    Topics: Autism Spectrum Disorder; Biological Specimen Banks; Codon, Nonsense; Germ Cells; Hematologic Diseases; Histone Demethylases; Humans; Lysine; Male; Mutation; Vestibular Diseases

2023
UTX-guided neural crest function underlies craniofacial features of Kabuki syndrome.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 10-24, Volume: 114, Issue:43

    Topics: Abnormalities, Multiple; Animals; Cell Survival; Disease Models, Animal; Face; Female; Gene Expression Regulation, Developmental; HEK293 Cells; Hematologic Diseases; Histone Demethylases; Humans; Lysine; Male; Mice, Knockout; Mice, Transgenic; Mutation; Neural Crest; Nuclear Proteins; Skull; Vestibular Diseases

2017